Table 2. Laboratory findings at the admission of COVID-19 patients.
Parameters | Total | Survivors | Non-survivors | p-value | |||
Median | IQR | Median | IQR | Median | IQR | ||
Hemogram | |||||||
Hemoglobin (g/L or g/dL) | 12.8 | 11.3-14.2 | 12.8 | 11.4-14.2 | 12.4 | 10.4-13.9 | 0.000* |
WBC (×103/uL) | 6.9 | 5.3-9.3 | 6.7 | 5.2-8.7 | 11.69 | 7.49-16.5 | 0.000* |
Lymphocyte count (%) | 24.5 | 14.4-13.4 | 26 | 17-35 | 8 | 4.9-13.6 | 0.000* |
Neutrophil count (cells/μL) | 63.5 | 52.5-76 | 61.7 | 51.5-72.8 | 85.2 | 79.4-90 | 0.000* |
Platelets (×103/uL) | 224 | 168-288 | 225 | 170-289 | 206 | 149.2-280.2 | 0.000* |
Liver function test | |||||||
AST/SGOT | 30 | 22-46 | 29 | 21-42 | 53 | 35-83 | 0.000* |
ALT/SGPT | 26 | 16-44 | 25 | 15-42 | 37 | 24.75-63 | 0.000* |
Total bilirubin (mg/dL) | 0.60 | 0.44-0.83 | 0.59 | 0.44-0.80 | 0.78 | 0.54-1.2 | 0.000* |
APTT | 29.1 | 26.9-32 | 29 | 26.8-31.6 | 32.1 | 28.1-36 | 0.000* |
PT (seconds) | 10.6 | 10-11.2 | 10.5 | 10-11.1 | 11.5 | 10.6-13.1 | 0.000* |
INR | 1 | 1-1.1 | 1 | 1-1.1 | 1.1 | 1-1.3 | 0.000* |
Glucose (mg/dL) | 98 | 88-125 | 98 | 87.7-122 | 205 | 122.25-323.25 | 0.000* |
Kidney function test | |||||||
Blood urea nitrogen (mg/dL) | 25 | 19-37 | 24 | 19-33 | 56 | 38-91 | 0.000* |
LDH | 482 | 366-657 | 468 | 358-611 | 847.23 | 406-995 | 0.000* |
Creatinine (mg/dL) | 1.1 | 0.9-1.27 | 1.08 | 0.90-1.2 | 1.22 | 1-1.8 | 0.000* |
Sodium (mmol/L) | 139 | 136-142 | 139 | 137-141 | 139 | 135-143 | 0.882 |
Potassium (mmol/L) | 4.1 | 3.7-4.5 | 4.06 | 3.7-4.4 | 4.42 | 1.01-6.6 | 0.000* |
Biomarkers | |||||||
CRP (mg/L) | 10.7 | 3-55 | 8 | 2-40.89 | 105.1 | 58.01-172.8 | 0.000* |
IL-6 | 24.3 | 4.8-105.3 | 6.8 | 2.2-678 | 60.1 | 11.5-148 | 0.035* |
D-dimer | 1.14 | 0.46-5.6 | 31.05 | 0.57 | 5.6 | 2.7-10.8 | 0.000* |
Ferritin | 203.8 | 80.2-477.3 | 291.30 | 173 | 814.1 | 446.7-1,475.3 | 0.000 |